Laboratory testing in autoimmune rheumatic diseases

Best Practice and Research: Clinical Rheumatology

Volumn 18, Issue 3, 2004, Pages 249-269

  Sheldon, Joanna ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Autoantibodies; Autoimmune diseases; Detection; Quantification

Indexed keywords

ANTIGEN; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; CELL NUCLEUS ANTIGEN; CENTROMERE ANTIBODY; COMPLEMENT; CRYOGLOBULIN; DOUBLE STRANDED DNA; IMMUNOGLOBULIN; LA ANTIGEN; NEUTROPHIL CYTOPLASMIC ANTIBODY; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; AUTOIMMUNE DISEASE; CELL DAMAGE; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; DISEASE MARKER; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE TEST; IMMUNOSTIMULATION; LABORATORY DIAGNOSIS; PATIENT MONITORING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; STANDARDIZATION; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; SYSTEMIC VASCULITIS; T LYMPHOCYTE; TISSUE INJURY;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; HUMANS; IMMUNOGLOBULINS; IMMUNOLOGIC TESTS; RHEUMATIC DISEASES; SENSITIVITY AND SPECIFICITY;

EID: 3242706035     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2004.03.007     Document Type: Review

References (65)

1. Waaler E. On the occurrence of a factor in human serum activating the specific agglutination of sheep corpuscles. Acta Pathologica et Microbiologica Scandinavica 1 1940 172-188
2. Natvig J.B. Gaarder P.I. Turner M.W. IgG antigens of the C gamma 2 and C gamma 3 homology regions interacting with rheumatoid factors. Clinical and Experimental Immunology 12 1972 177-184
3. Jonsson T. Valdimarsson H. Is measurement of rheumatoid factor isotypes clinically useful? Annals of the Rheumatic Diseases 52 1993 161-164
4. Shmerling R.H. Delbanco T.L. The rheumatoid factor: An analysis of clinical utility American Journal of Medicine 91 1991 528-534
5. Withrington R.H. Teitsson I. Valdimarsson H. Seifert M.H. Prospective study of early rheumatoid arthritis. II. Association of rheumatoid factor isotypes with fluctuations in disease activity. Annals of the Rheumatic Diseases 43 1984 679-685
6. Moore T.J. Rheumatoid factors. Clinical Immunology Newsletter 18 1988 89-96
7. Laxer R. Schneider R. Systemic-onset juvenile chronic arthritis In Maddison P. Eisenberg D. Woo P. Glass D.N. (Eds.) Oxford Textbook of Rheumatology second edn 1998 1114-1131 Oxford University Press Oxford
8. Schellekens G.A. de Jong B.A. van den Hoogen F.H. et a.l Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis specific antibodies Journal of Clinical Investigation 101 1998 273-281
9. Schellekens G.A. Visser H. de Jong B.A. et al The diagnostic properties of rheumatoid arthritis antibodies recognising a cyclic citrullinated peptide. Arthritis and Rheumatism 42 2000 155-163
10. van Jaarsveld C.H.M. ter Borg E.J. Jacobs J.W.G. et al. The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clinical and Experimental Rheumatology 17 1999 689-697
11. Kroot E.J.A. de Jong B.W. van Leeuwen M.A. et al. The prognostic value of anti-cyclic sitrullinated peptide antibody in patients with recent-onset rheumatoid arthritis Arthritis and Rheumatism 43 2000 1831-1835
12. Visser H. le Cessie S. Vos K. et al How to diagnose rheumatoid arthritis early. A prediction model for persistent (erosive) arthritis Arthritis and Rheumatism 46 2002 357-365
13. Lock R.J. Unsworth D.J. Antibodies to extractable nuclear antigens. Has technological drift affected clinical interpretation? Journal of Clinical Pathology 54 2001 187-190
14. Swaak T. Smeenk R.J. Detection of anti-dsDNA as a diagnosis tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsNDA antibody (anti-dsDNA) Annals of the Rheumatic Diseases 44 1985 245-251
15. ter Borg E.J. Horst G. Hummell E.J. et al Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long term, prospective study Arthritis and Rheumatism 33 1990 634-643
16. Manoussakis M.N. Kistis K.G. Liu X. et al Detection of anti Ro(SSA) antibodies in autoimmune diseases: comparison of five methods British Journal of Rheumatology 32 1993 449-455
17. Behan W.M.H. Behan P.O. Reid J.M. et al Family studies in congenital heart block associated with Ro antibody British Heart Journal 62 1989 320-324
18. Gottlieb E. Steitz J.A. Function of the mammalian La protein: evidence for its activity in transcription termination by RNA polymerase III European Molecular Biology Organization Journal 8 1989 851-861
19. Manoussakis M.N. Kistis K.G. Liu X. et al Detection of human-specific anti La(SSB) antibodies patients with rheumatoid arthritis Journal of Autoimmunity 8 1995 959-969
20. James J.A. Dickey D.J.D. Fujisaka A. et al Antigenicity of a recombinant Ro(SS-A) fusion protein Arthritis and Rheumatism 33 1990 102-106
21. Venables P.J.W. Charles P.J. Buchannan R.C. et al Quantitation and detection of isotypes of anti SS-B antibodies by ELISA and Farr assays using affinity purified antigens Arthritis and Rheumatism 26 1982 146-155
22. Bunn C.C. Denton C.P. Shi-Wen X. et al Anti RNA polymerase and other autoantibody specificities in systemic sclerosis British Journal of Rheumatology 37 1998 15-20
23. Habets W.J. Berden J.H.M. Hoch S.O. van Venrooji W.J. Further characterisation and subcellular localisation of Sm and U1-ribonuclearprotein antigens European Journal of Immunology 15 1985 992-997
24. Holyst M.M. Hoffman R.W. U-small nuclear ribonucleoprotein (RNP) reactive autoantibodies: diagnostic testing and clinical interpretation Clinical Immunology Newsletter 18 1998 53-57
25. Panush R.S. Edward N.G. Longley S. Webster E. 'Rhupus' syndrome Archives of Internal Medicine 148 1988 1633-1636
26. ter Borg E.J. Groen H. Horst G. et al Clinical association of antiribonuclearprotein antibodies in patients with systemic lupus erythematosus Seminars in Arthritis and Rheumatism 20 1990 164-173
27. Shero J.H. Bordwell B. Rothfield N. et al. High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients Science 231 1986 737-740
28. Harvey G.R. Butts S. Rands A.L. et al Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis Clinical and Experimental Immunology 117 1999 395-402
29. Marguerie C.M. Bunn C.C. Copier J. et al The clinical and immunogenic features of patients with autoantibodies to the nuclear antigen PM-Scl Medicine 71 1992 327-336
30. Bernstein R.M. Steigerwald J.C. Tan E.M. Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis Clinical and Experimental Immunology 48 1982 43-51
31. Earnshaw W. Bordwell B. Marino C. Rothfield N. Three human chromosomal autoantigens are recognised by sera from patients with anticentromere antibodies Journal of Clinical Investigation 77 1986 426-430
32. McHugh N.J. James I.E. Kairburn K. et al Autoantibodies to mitochondrial and centromere antigens in primary biliary cirrhosis and systemic sclerosis Clinical and Experimental Immunology 81 1990 244-249
33. Bernstein R.M. Autoantibodies in myositis Baillière's Clinical Neurology 2 1993 599-616
34. Targoff I.N. Humoural immunity in polymyositis/dermatomyositis Journal of Investigative Dermatology 100 1995 116s-123s
35. Polz P.H. Dalakas M. Leff R.L. et al Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis and related disorders Annals of Internal Medicine 11 1989 143-157
36. Jennette J.C. Falk R.J. Andrassy K. et al Nomenclature of systemic vasculitides-proposal of an international consensus conference Arthritis and Rheumatism 37 1994 187-192
37. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA Acta Pathologica, Microbiologica, et Immunologica Scandinavica 97 supplement 6 1989 12-13
38. Savige J. Gillis D. Benson E. et al International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA) American Journal of Clinical Pathology 111 1999 507-513
39. Ludeman J. Utect B. Gross W.L. Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme Journal of Experimental Medicine 171 1990 357-362
40. Wong R.C.W. Silvestrini R.A. Savige J.A. et al Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns Journal of Clinical Pathology 52 1999 124-128
41. Kallenberg C.G.M. Brouwer E. Weening J.J. Cohen Tervaert J.W. Anti neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential Kidney International 46 1994 1-15
42. Hagen E.C. Daha M.R. Heremans J. et al Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis Kidney International 53 1998 743-753
43. Franssen C.F.M. Gans R.O.B. Kallenberg C.G.M. et al Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti myeloperoxidase autoantibodies Journal of Internal Medicine 244 1998 209-216
44. Geffriaud-Ricouard C. Noel L.H. Chaveau D. et al Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients Clinical Nephrology 39 1993 125-136
45. Westman K.W. Bygren P.G. Olsson H. et al Relapse rate, renal survival and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement Journal of the American Society of Nephrology 9 1998 842-852
46. Heeringa P. Brouwer E. Cohen Tervaert J.W. et al Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis Kidney International 53 1998 253-263
47. Muller Kobold A.C. van der Geld Y.M. Limburg P.C. et al Pathophysiology of ANCA-associated glomerulonephritis Nephrolology, Dialysis and Transplantation 14 1999 1366-1375
48. van der Woude F.J. Rasmussen N. Lobatto S. et al Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis Lancet ii 1985 425-429
49. Jayne D.R. Gaskin G. Pusey C.D. Lockwood C.M. ANCA and predicting relapse in systemic vasculitis Quarterly Journal of Medicine 88 1995 127-133
50. Egner W. Chapel H.M. Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides Clinical and Experimental Immunology 82 1990 244-249
51. De'Oliveira J. Gaskin G. Dash A. et al Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis American Journal of Kidney Disease 25 1995 380-389
52. Hagen E.C. Daha M.R. Heremans J. et al Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis Kidney International 53 1998 743-753
53. Han W.K. Choi W.K. Roth R.M. et al Serial ANCA titres: useful tool for prevention of relapses in ANCA associated vasculitis Kidney International 63 2003 1079-1085
54. Amengual O. Atsumi T. Khamashta M.A. et al Specificity of ELISA for antibody to beta 2 glycoprotein 1 in patients with antiphospholipid syndrome British Journal of Rheumatology 35 1996 1239-1243
55. Hughes G.R.V. Thrombosis, abortion, cerebral disease and lupus anticoagulant British Medical Journal 187 1983 1088-1089
56. Milford Ward A. White P.A.E. Measuring cardiolipin antibodies British Medical Journal 310 1995 1472-1473
57. Wilson W.A. Gharavi A.E. Koike T. et al Interntional consensus on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop Arthritis and Rheumatism 42 1999 1309-1311
58. Harley J.B. Autoantibodies in Sjögren's syndrome In Talal N. Moutsopolous H.M. Kassan S.S. (Eds.) Sjögren's Syndrome: Clinical and Immunological Aspects 1987 218-234 Springer Berlin
59. Colley C.M. Fleck A. Goode A.W. et al Early time course of the acute phase protein response in man Journal of Clinical Pathology 36 1983 203-207
60. McConkey B. Crockson R.A. Crockson A.P. The assessment of rheumatoid arthritis: a study based on measurement of the serum acute phase reactants Quarterley Journal of Medicine 41 1972 115-125
61. Pepys M.B. Serum C-reactive protein, serum amyloid P component and serum amyloid A protein in autoimmune disease Clinics in Immunology and Allergy 1 1981 77-101
62. Becker G.J. Waldburger M. Hughes G.R.V. Pepys M.B. Value of serum C-reactive protein measurements in the investigation of fever in systemic lupus erythematosus Annals of the Rheumatic Diseases 39 1980 50-52
63. Hind C. Winearls C.G. Pepys M.B. Correlation of disease activity in systemic vasculitis with serum C-reactive protein measurement European Journal of Clinical Investigation 15 1985 89-94
64. Ruddy S. Gigli I. Austen K.F. The complement system of man. I-IV New England Journal of Medicine 287 1972 642-646
65. Frank M.M. Complement in the pathophysiology of human disease New England Journal of Medicine 316 1987 1525-1530